PURPOSE/OBJECTIVE: The objective of this study is to evaluate the dosimetric parameters in adaptive radiotherapy
for locally advanced head and neck cancers
METHODS AND MATERIALS: This is a Hospital-based Prospective study conducted in the period from Dec 2020 to March 2021.
Histologically proven Head and Neck Carcinoma patients with Stage III to IV (locally advanced) were selected for the study. A total of 10
patients receiving denitive, conformal radiation therapy to the head and neck region were evaluated for the study. After the acquisition of CT
images, target volumes, OARs were contoured in the planning CT. Images were again acquired midway during the planned course of radiation
therapy. Body contours, target volumes, and organs at risk were redrawn on the new set of images. Two sets of additional treatment plans were
generated: 1) a non-optimized plan (plan 2), which is an overlay of the original plan (plan 1) on the new set of contours, and 2) an optimized
plan(plan 3) with the new set of contours. These 3 sets of plans were then compared for dosimetric differences.
RESULTS: Four patients had locally advanced nasopharyngeal cancers, 4 patients had locally advanced oropharyngeal cancers, 2 patients had
locally advanced hypopharyngeal cancer. The average reduction in gross tumour volume was 37.1 ml. The average changes in right and left
parotid volume were 5.94 and 5.49 ml, respectively. With the non-optimized plan, the average increase in the maximum dose to the spinal cord
was 9.8% (58.96-68.76; p= 0.156). With reoptimization, the maximum dose to the spinal cord decreased from 68.76% to 54.97% (mean
difference, -13.79%, p=0.03). The average D99 for the planning target volume( dose received by 99% of the target volume) was 98.68% and
98.65% with the original and reoptimized plans, respectively. Most of the patients during radiation had Grade 2 skin toxicity and Grade 2
mucositis which was managed conservatively.
CONCLUSIONS: This study demonstrates that during radiation there is gross changes of volumes in locally advanced head and neck cancers
and thus adaptive radiation therapy plays a pivotal role in locally advanced head and neck cancer